Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma

This publication has 17 references indexed in Scilit:

• Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution
  Diseases of the Esophagus, 2006
• Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus
  Diseases of the Esophagus, 2006
• Significance of COX-2 expression in human esophageal squamous cell carcinoma
  Carcinogenesis, 2005
• High Cyclooxygenase-2 Expression Following Neoadjuvant Radiochemotherapy Is Associated with Minor Histopathologic Response and Poor Prognosis in Esophageal Cancer
  Clinical Cancer Research, 2005
• Prognostic role of cyclooxygenase‐2 in neoadjuvant‐treated patients with squamous cell carcinoma of the esophagus
  International Journal of Cancer, 2005
• Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus
  The American Journal of Surgery, 2005
• COX-2: a target for prevention and treatment of esophageal cancer
  Journal of Surgical Research, 2004
• Host cyclooxygenase-2 modulates carcinoma growth
  Journal of Clinical Investigation, 2000
• Long-Term Results of Subtotal Esophagectomy with Three-Field Lymphadenectomy for Carcinoma of the Thoracic Esophagus
  Annals of Surgery, 1994
• Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.
  Proceedings of the National Academy of Sciences, 1991